DDW’s Megan Thomas discusses the opportunity in the multi-omics sector by speaking with leading players and looking at the ways in which it can help us tackle disease. Importance of the multi-omics sector Multi-omics describes the crossover application of many high‐throughput screening technologies. These include genomics, transcriptomics, proteomics, metabolomics, epigenomics, glycomics, lipidomics, phosphoproteomics, and more. Whether […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!